Immunomedics (IMMU) Acquisition
Gilead Sciences (GILD) and Immunomedics (IMMU) $21bn acquisition information including expected completion date, offer price and contact details are displayed in the acquisition details table…
Gilead Sciences (GILD) and Immunomedics (IMMU) $21bn acquisition information including expected completion date, offer price and contact details are displayed in the acquisition details table…
Gilead Sciences (GILD) and Forty Seven (FTSV) $4.9bn acquisition information is displayed in the merger details table. This buyout factsheet, including expected completion date and offer price, is an invaluable data source for traders & investors looking to familiarize themselves with the Gilead Sciences (GILD) takeover of Forty Seven (FTSV) and trade the merger arbitrage spread.